路透纽约12月2日 - 美国曼哈顿联邦检察官杰伊-克莱顿（Jay Clayton）周二表示，CVS Health CVS.N将支付3776万美元，以解决其向患者配发过多胰岛素笔，然后向政府医疗保健项目寻求报销的指控。
该和解协议解决了对 CVS 违反《联邦虚假索赔法》（False Claims Act）的指控，即 CVS 为患者配发的胰岛素笔数量超过了医生开具的处方数量，为过早补充胰岛素获取报销，以及少报药房配发的胰岛素数量。
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.